Salt Name: imetelstat.  It is used to treat patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS).

RYTELO is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).

Generic Name: imetelstat
Strength: • For injection: 47 mg powder in a single-dose vial for reconstitution.
• For injection: 188 mg powder in a single-dose vial for reconstitution.
Manufacturer: Geron Corporation
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “RYTELO (imetelstat)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for RYTELO (imetelstat) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more